Past, present, and future of immunotherapy research in liver neoplasms: A bibliometric and visualization analysis

肝脏肿瘤免疫疗法研究的过去、现在和未来:文献计量学和可视化分析

阅读:3

Abstract

Liver neoplasms seriously threaten the lives and health of people worldwide and immunotherapies have shown remarkable therapeutic improvements in treating liver neoplasms in recent years. This study aims to provide a summary of the current state of research, key discoveries, and next directions in the field of liver neoplasms immunotherapy using bibliometrics. Researches search and data collection from Web of Science Core Collection. Calculations and visualizations were performed using Microsoft Excel, CiteSpace. For the previous 10 years (2014-2024), we identified 1663 English articles about immunotherapy for liver neoplasms, and that the number of articles increased more quickly after 2021. China, the Chinese Academy of Sciences, and Greten, Tim F are the country, institution, and writer with the most publications. The most cited reference was published by Finn RS in 2020. After 2021, people are paying more and more attention to liver neoplasms. There is a direct relationship between the incidence of liver neoplasms and the number of papers published, but the relationship between developed and developing countries is not close. Some areas of intense investigation in this discipline are sorafenib, tumor microenvironment, t cells, and dendritic cells.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。